These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23478586)

  • 61. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
    Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT
    AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis.
    Soydal C; Kucuk NO; Balci D; Gecim E; Bilgic S; Elhan AH
    Cancer Biother Radiopharm; 2016 Nov; 31(9):342-346. PubMed ID: 27831761
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.
    Grut H; Revheim ME; Line PD; Dueland S
    Nucl Med Commun; 2018 Jul; 39(7):621-627. PubMed ID: 29683930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases.
    Nishioka Y; Yoshioka R; Gonoi W; Sugawara T; Yoshida S; Hashimoto M; Shindoh J
    Abdom Radiol (NY); 2018 May; 43(5):1152-1158. PubMed ID: 28815337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
    Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.
    Wong CY; Qing F; Savin M; Campbell J; Gates VL; Sherpa KM; Lewandowski RJ; Nagle C; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1101-6. PubMed ID: 16105922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis.
    Xia Q; Liu J; Wu C; Song S; Tong L; Huang G; Feng Y; Jiang Y; Liu Y; Yin T; Ni Y
    Cancer Imaging; 2015 Nov; 15():19. PubMed ID: 26589835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
    Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical outcome prediction of percutaneous cementoplasty for metastatic bone tumor using (18)F-FDG PET-CT.
    Kim YI; Kang HG; Kim SK; Kim JH; Kim HS
    Ann Nucl Med; 2013 Dec; 27(10):916-23. PubMed ID: 24072606
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
    Schmidt GP; Paprottka P; Jakobs TF; Hoffmann RT; Baur-Melnyk A; Haug A; Notohamiprodjo M; Baur-Melnyk A; Nikolaou K; Reiser MF; Rist C
    Eur J Radiol; 2012 Mar; 81(3):e269-76. PubMed ID: 21398060
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
    Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
    Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
    Fonti R; Larobina M; Del Vecchio S; De Luca S; Fabbricini R; Catalano L; Pane F; Salvatore M; Pace L
    J Nucl Med; 2012 Dec; 53(12):1829-35. PubMed ID: 23071351
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
    Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; Philips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA
    Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Yttrium-90 radioembolization in patients with unresectable liver metastases: determining the factors that lead to treatment efficacy.
    Gunduz S; Ozgur O; Bozcuk H; Coşkun HS; Ozdogan M; Erkilic M; Sindel T; Yldlzs A; Ylmaz S; Boz A; Aydin F; Karayalçin B; Savas B
    Hepatogastroenterology; 2014 Sep; 61(134):1529-34. PubMed ID: 25436337
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.